Paediatric anaesthesia
-
Paediatric anaesthesia · Jun 2023
Randomized Controlled TrialComparison of Ambu AuraGain and BlockBuster laryngeal mask for controlled ventilation in children undergoing minor surgical procedures under general anesthesia: A prospective randomized controlled study.
Ambu AuraGain has proven to be better compared with other supraglottic airway devices in terms of higher first-attempt insertion success rate, time and ease of insertion, high oropharyngeal leak pressure, and fewer complications in children. The performance of the BlockBuster laryngeal mask has not been evaluated in children. ⋯ We found that the BlockBuster laryngeal mask has higher oropharyngeal leak pressure compared with Ambu AuraGain in a pediatric population.
-
Paediatric anaesthesia · Jun 2023
Case ReportsUnexpectedly low oxygen saturation in a child with a variant hemoglobin.
We report a child with an unexpected low saturation reading despite normal values having been recorded soon after birth. A family history of Rothschild hemoglobin variant affecting the father was obtained. Saturation values improved with oxygen and anesthesia was uneventful. The development of low saturation values as the child matures is explained, and management for future health presentations outlined.
-
Paediatric anaesthesia · Jun 2023
PAN-2022-0245 Manuscript title: Relationship between decrement time and recovery time in pediatric total intravenous anesthesia with propofol and remifentanil.
Propofol target-controlled infusion is now used in many countries for the administration of total intravenous anesthesia (TIVA) and uses population pharmacokinetic data incorporated into the target-controlled infusion pump to administer a dose which will achieve a target concentration selected by the practitioner. Modern target-controlled infusion pumps can include an estimate of how long it will take for the plasma propofol concentration to fall to a value programmed into the pump, once the propofol infusion is stopped. This is known as decrement time. Many users consider decrement time to be equivalent to recovery time for the patient, despite the several assumptions that makes. ⋯ There was variation between decrement time to 1.5 μg.mL-1 and recovery time of over 5 min in nearly half of patients. Decrement time to 1.5 μg.mL-1 must be used with caution when trying to predict recovery time for individual patients following TIVA.